|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
Posted on: 10/29/2009, by Barbara Belardi
Michael Shullo, PharmD, assistant professor of pharmacy and therapeutics, has co-authored a manuscript titled "Alemtuzumab Induction Prior to Cardiac Transplantation with Lower Intensity Maintenance Immunosuppression: One-Year Outcomes" with Jeffrey Teuteberg, MD, assistant professor of medicine. The manuscript has been accepted for publication by the American Journal of Transplantation.